New medical devices are developed to enable quicker, easier and safer surgery. This will reduce risk of complications and shorten time needed for recovery.
Absorbable/resorbable medical devices are left in the body where after they are safely resorbed by the tissue.
The innovative resorbable surgical products of the company are unique and protected by patent(s). Devices in development are intended for urology and orthopaedics. LigaTie® is initially intended for veterinary surgery and is clinically tested.
LigaTie® resorbable self-locking loop.
K Ishigaki et al. Vet Surgery 2021 https://doi.org/10.1111/vsu.13623
K Ishigaki et al. Vet Surgery 2021: Open access, "read only"-link
Video, Guedes et al: Watch the operation (video is open access, access to journal is required to view publication).
Cystic duct pressures after ligation with a novel absorbable device in an ex vivo caprine cholecystectomy model, by Sundholm Tepper et al, in The Canadian Journal of Veterinary Research, 2017;81:223-227
Ligation of the mesovarium in dogs with a self-locking implant of a resorbable polyglycolic based co-polymer: a study of feasability and comparison to suture ligation, by da Mota Costa et al in BMC Research Notes, April 2016
PhD thesis, development project and initial tests of LigaTie®: A resorbable device for ligation of blood vessels. Subtitle: Development, assessment of surgical procedures and clinical evaluation. 2012
Interested to try the LigaTie®? Drop us an e-mail!
Resorbable Devices AB
CEO Odd Viking Höglund, DVM, PhD
Phone: +46703-29 89 50